Regencell Bioscience Holdings Ltd (RGC)
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Sector: Medicinal Chemicals & Botanical Products
Industry: Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Limited
NASDAQ:RGCHealthcare · Drug Manufacturers - Specialty & Generic
-11.86%$6.76
AH Close$6.71-0.77%vs close
AH Close$6.71-0.77%vs close
Mkt Cap$3.35B
Float17.8M
O/S495.88M
Inst Own0.3%
SI2.5%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$11.7M
Total Assets$14.73M
Free Cash Flow-$7.7M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$296K
Total Equity$13.35M
Shares Outstanding
Short Interest
Split History1 split
- 38:1Forward splitJun 16, 20251 share → 38
Balance Sheet Details
Assets$14.73M
Liabilities$1.38M
Accounts Receivable$0
Accounts Payable$0
Inventory$0
PP&E (Net)$431K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $405K | $393K | $746K | $770K | $604K | $26K | $10K | $0 |
| Gross Profit | -$405K | -$393K | -$746K | -$770K | -$604K | -$26K | -$10K | $0 |
| Gross Margin | - | - | - | - | - | - | - | - |
| Research and Development | $1.3M | $948K | $1.07M | $1.58M | $2.51M | $438K | $386K | $228K |
| Selling, General, and Administrative | $10.02M | $2.43M | $2.92M | $4.69M | $5.11M | $943K | $426K | $163K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $11.32M | $3.38M | $3.99M | $6.27M | $7.62M | $1.38M | $812K | $391K |
| Operating Income (EBIT) | -$11.72M | -$3.77M | -$4.74M | -$6.27M | -$7.62M | -$1.38M | -$812K | -$391K |
| Operating Margin | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $23K | $186K | $374K | $211K | $23K | $35K | $0 | $0 |
| Income Before Tax (EBT) | -$11.7M | -$3.58M | -$4.36M | -$6.06M | -$7.59M | -$1.35M | -$812K | -$391K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$391 |
| Net Income | -$11.7M | -$3.58M | -$4.3M | -$5.87M | -$7.42M | -$1.35M | -$812K | -$391K |
| Net Income Margin | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
| Diluted EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
| Weighted Average OS | 494.60M | 494.49M | 494.49M | 494.49M | 494.49M | 480.40M | 480.40M | 480.40M |
| EBITDA | -$11.32M | -$3.19M | -$3.62M | -$5.29M | -$6.99M | -$1.35M | -$803K | $0 |
| EBITDA Margin | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $14.19M | $2.42M | $2.96M | $1.56M | $6.42M | $59K | $387K | $243K |
| Short-Term Investments | $0 | $2.48M | $5M | $10M | $10M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $14.19M | $4.9M | $7.96M | $11.56M | $16.42M | $59K | $387K | $243K |
| Accounts Receivable | $0 | $0 | $153K | $57K | $28K | $7K | $0 | $0 |
| Inventory | $0 | $0 | $0 | -$57K | -$28K | $0 | $0 | $0 |
| Other Current Assets | $31K | $6K | $0 | $0 | $0 | -$7K | $0 | $0 |
| Total Current Assets | $14.22M | $4.9M | $8.11M | $11.62M | $16.44M | $67K | $387K | $243K |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $431K | $760K | $227K | $892K | $1.46M | $82K | $108K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $76K | $93K | $98K | $108K | $114K | $191K | $19K | $0 |
| Total Long-Term Assets | $506K | $853K | $324K | $1M | $1.57M | $273K | $127K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $14.73M | $5.76M | $8.44M | $12.62M | $18.02M | $340K | $514K | $243K |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Short-Term Debt | $236K | $313K | $0 | $0 | $0 | $3.68M | $3.07M | $2.08M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1.08M | $351K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $1.32M | $664K | $194K | $607K | $578K | $4.34M | $3.16M | $2.08M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $59K | $232K | $26K | $25K | $360K | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.38M | $895K | $220K | $632K | $938K | $4.34M | $3.16M | $2.08M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $5K | $5K | $130 | $130 | $130 | $100 | $100 | $100 |
| Retained Earnings | -$36.9M | -$25.2M | -$21.62M | -$17.32M | -$11.44M | -$4M | -$2.65M | -$1.84M |
| Comprehensive Income & Other | -$45K | -$65K | -$46K | -$87K | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $50.25M | $30.06M | $29.84M | $29.35M | $28.51M | $256 | $256 | $256 |
| Total Equity | $13.35M | $4.86M | $8.22M | $12.03M | $17.07M | -$4M | -$2.65M | -$1.84M |
| Minority Interest | $0 | $0 | $0 | -$41K | $15K | $0 | $0 | $0 |
| Total Liabilities and Equity | $14.73M | $5.76M | $8.44M | $12.66M | $18M | $340K | $514K | $243K |
| Supplementary Data | ||||||||
| Total Debt | $296K | $544K | $86K | $464K | $771K | $3.68M | $3.07M | $2.08M |
| Net Debt | -$13.9M | -$1.87M | -$2.88M | -$1.1M | -$5.65M | $3.62M | $2.68M | $1.84M |
Cash Flow Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Operating Activities | ||||||||
| Net Income | -$11.7M | -$3.58M | -$4.36M | -$5.87M | -$7.45M | -$1.35M | -$812K | -$391K |
| Depreciation & Amortization | $405K | $393K | $746K | $770K | $604K | $26K | $10K | $391K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $245K | $449K | $930K | $2.76M | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $399K | $19K | -$585K | -$509K | -$1.02M | $553K | $76K | $0 |
| Total Working Capital Change | $399K | $19K | -$585K | -$509K | -$1.02M | $553K | $76K | $0 |
| Other Non-Cash Items | $3.2M | $59K | -$248K | -$283K | -$159K | $0 | $0 | -$391K |
| Net Cash from Operating | -$7.7M | -$3.11M | -$4M | -$4.96M | -$5.27M | -$767K | -$727K | -$391K |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | -$153K | -$5K | -$27K | -$781K | $0 | -$118K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$32.48M | -$5M | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $2.5M | $35.32M | $10.25M | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $86K | -$10M | $0 | $0 | $0 |
| Net Cash from Investing | $2.5M | $2.69M | $5.24M | $59K | -$10.78M | $0 | -$118K | $0 |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $18.72M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | -$1.78M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $102K | $135K | $22.41M | $440K | $988K | $0 |
| Net Cash from Financing | $16.95M | $0 | $102K | $135K | $22.41M | $440K | $988K | $481K |
| Forex Effect | $19K | -$115K | $53K | -$83K | $0 | $0 | $0 | $0 |
| Net Change in Cash | $11.77M | -$542K | $1.4M | -$4.85M | $6.36M | -$328K | $144K | $90K |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$7.7M | -$3.11M | -$4M | -$4.96M | -$5.27M | -$767K | -$727K | -$391K |
| Capital Expenditure | $0 | -$153K | -$5K | -$27K | -$781K | $1 | -$118K | $0 |
| Free Cash Flow | -$7.7M | -$3.27M | -$4.01M | -$4.99M | -$6.05M | -$767K | -$844K | -$391K |
| Cash at Beginning | $2.42M | $2.96M | $1.56M | $6.42M | $59K | $387K | $243K | $153K |
| Cash at End | $14.19M | $2.42M | $2.96M | $1.56M | $6.42M | $59K | $387K | $243K |